Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Principia appoints chief business officer

This article was originally published in Scrip

Executive Summary

Principia Biopharma, a private, clinical-stage biopharmaceutical company, has appointed Roy Hardiman to the newly created position of chief business officer. Mr Hardiman joins the company from Genentech where he held various senior level positions including vice-president of alliance management; vice-president of corporate law; and assistant secretary and director of business and corporate development. Mr Hardiman is also on the board of trustees for the University of California, Santa Barbara Foundation.

Topics

Related Companies

UsernamePublicRestriction

Register

SC027553

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel